BOSTON SCIENTIFIC CORPORATION Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest
BOSTON SCIENTIFIC CORPORATION (BSX) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest of $4.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest · last filed 2026-08-03
- BOSTON SCIENTIFIC CORPORATION other comprehensive income (loss), net of tax, portion attributable to noncontrolling interest for the quarter ending 2026-06-30 was $4.00M, a 33.33% increase year-over-year.
- BOSTON SCIENTIFIC CORPORATION other comprehensive income (loss), net of tax, portion attributable to noncontrolling interest for the quarter ending 2026-03-31 was $3.00M, a 50.00% increase year-over-year.
- BOSTON SCIENTIFIC CORPORATION other comprehensive income (loss), net of tax, portion attributable to noncontrolling interest for the quarter ending 2025-09-30 was $1.00M, a 90.00% decline year-over-year.
- BOSTON SCIENTIFIC CORPORATION other comprehensive income (loss), net of tax, portion attributable to noncontrolling interest for the quarter ending 2025-06-30 was $3.00M.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest 3 month as first filed | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest 9 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest 9 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $4.00M 10-Q · filed 2026-08-03 | $7.00M 10-Q · filed 2026-08-03 | |||
| 2026-03-31 | $3.00M 10-Q · filed 2026-05-01 | ||||
| 2025-09-30 | $1.00M 10-Q · filed 2025-11-03 | $4.00M derived: sum of 2 quarters · filed 2026-08-03 | $7.00M 10-Q · filed 2025-11-03 | ||
| 2025-06-30 | $3.00M 10-Q · filed 2026-08-03 | $6.00M 10-Q · filed 2026-08-03 | |||
| 2025-03-31 | $2.00M 10-Q · filed 2026-05-01 | ||||
| 2024-09-30 | $10.00M 10-Q · filed 2025-11-03 | -$10.00M 10-Q · filed 2024-11-01 | $9.00M derived: sum of 2 quarters · filed 2025-11-03 | $4.00M 10-Q · filed 2025-11-03 | -$4.00M 10-Q · filed 2024-11-01 |
| 2024-06-30 | -$1.00M 10-Q · filed 2025-08-01 | -$6.00M 10-Q · filed 2025-08-01 | |||
| 2024-03-31 | -$5.00M 10-Q · filed 2025-05-01 | ||||
| 2023-09-30 | $16.00M 10-Q · filed 2024-11-01 | $16.00M derived: sum of 2 quarters · filed 2024-11-01 | $16.00M 10-Q · filed 2024-11-01 | ||
| 2023-06-30 | $0.00 10-Q · filed 2024-08-01 | $0.00 10-Q · filed 2024-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |